Trial Profile
Open Label, One-arm, 3-month Study of Once-daily Tablet of V3-OVA as Immunotherapy of Ovarian Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs V3-OVA (Primary)
- Indications Ovarian cancer
- Focus Therapeutic Use
- Sponsors Immunitor
- 22 Jun 2018 New trial record